PharmD, BCPS
Clinical Pharmacy SpecialistHollings Cancer CenterMedical University of South CarolinaCharleston, South Carolina
Regardless of the stage of immune thrombocytopenia (ITP), previously referred to as idiopathic thrombocytopenic purpura, treatment decisions must take into account an individual’s preferences as well as comorbidities, bleeding, the urgency to increase the platelet count, and potential advantages and adverse effects of each treatment.
To sign up for our newsletter or print publications, please enter your contact information below.